Topics

Articles

PreHevbrio is the only 3-antigen vaccine for Hepatitis B approved for adults

Hepatitis B vaccine for adults approved by FDA

Is more testing the answer to a worsening drug crisis?

Physicians fear harmful drug abuse went unnoticed during the COVID-19 pandemic

The "Cures 2.0" bill, if signed into law, would expand medical research, aid development of new therapies and expand telehealth. 

Cures 2.0 legislation introduced: Would fund disease research, telehealth expansion

The product is the first interchangeable insulin biosimilar approved by the FDA.

Insulin biosimilar Semglee launches in U.S.

Healthcare staffing shortages exacerbated by the COVID-19 pandemic have intensified an already serious problem in healthcare: clinician burnout.

How care management tools can mitigate clinician burnout

I do not use annual visits for disease management but rather health promotion.

Use the annual exam to make patients healthier

Until now, measures to prevent cardiovascular diseases have focused almost entirely on individual behavioral and metabolic risk factors.

Cardiovascular disease and air pollution: how doctors can help patients cope

Keith Loria is a contributing writer to Medical Economics.

How medical practices can create effective vaccination programs for the months ahead

Preparing your practice for an efficient flu season

As we move beyond COVID-19, The healthcare industry is just beginning to uncover the impact of delayed cancer screenings and care on oncology outcomes.

Why cancer outcomes could depend on AI care coordination

Mark Denissen serves as the president and chief executive officer of 

. He has a storied career in the technology sector. Mr. Denissen worked more than three decades with Texas Instruments (TI), serving in various roles before becoming the Vice President of Worldwide Strategic Marketing. In this role, he was responsible for the startup of businesses such as Medical Devices, LED lighting solutions, and motor control solutions. Additionally, he was responsible for the commercialization of breakthrough technologies developed in Kilby Labs, TI’s long-range research and development center, and worked directly with TI’s Chief Technical Officer to move numerous projects towards commercialization. He holds a BSEE degree from the University of California Los Angeles.

Proper implementation of remote patient monitoring can be beneficial for practices and patients.

Chronic Conditions